Skip to main content

Table 4 sP-selectin, vWF:Ag, and ADAMTS levels, vWF/ADAMTS-13 ratios and respective delta values between baseline and postchemotherapy (n = 40)

From: Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy

Covariate

Baseline

Postchemotherapy

Difference in the median (delta value)

p §

sP-selectin (ng/mL)

81.95 (31.30–230.60)

92.5 (40.9–278.3)

+ 7.70 (1.0–88.1)

< 0.001

vWF:Ag (IU/mL)

1.30 (0.37–3.75)

1.50 (0.72–3.97)

+ 0.21 (0.02–1.22)

< 0.001

ADAMTS-13 antigen (IU/mL)

0.86 (0.42–1.33)

0.94 (0.31–1.64)

+ 0.03 (−0.39–0.36)

0.026

vWF:Ag/ ADAMTS-13 ratio

1.46 (0.39–8.33)

1.7 (0.56–12.80)

+ 0.17 (−1.24–4.47)

0.001

  1. Data are presented as the median (minimum-maximum range)
  2. NOTE: §Wilcoxon signed-rank test (between baseline and postchemotherapy)